ArticleBMC bioinformatics2025
SVhet: towards accurate detection of germline heterozygous deletions using short reads.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAccurate structural variant detection from short-read sequencing data remains challenged by false positives, particularly for heterozygous deletions where reduced allelic support and coverage-based detection methods are ambiguous. Existing SV genotyping and filtering approaches suffer from significant recall reductions, dependencies on additional pre-computed resources, or restriction to depth-based signals that overlook read level evidence.
resultsHere we present SVhet, a novel computational framework that leverages the heterozygosity patterns detected from different read evidences to identify false heterozygous deletions. Comprehensive benchmarking using 31 Human Genome Structural Variation Consortium Phase 3 samples demonstrated SVhet's ability to further reduce false positives while maintaining baseline recall. Hybrid approach of duphold and SVhet achieved up to 60% reduction in false positive counts while preserving recall. We also showed SVhet to be computationally efficient that can complete a whole genome structural variant callset under 5 min using 4 CPU cores. SVhet is available under a permissive MIT license via https://github.com/snakesch/SVhet .
conclusionSVhet provides an accurate and efficient solution for evaluating heterozygous deletions derived from short read sequencing data. SVhet can be used as a standalone tool or in conjunction with other filtering tools such as duphold. Importantly, it does not require additional variant sets, and can operate with minimal compute. Altogether, SVhet adds to the current effort to achieve accurate structural variant detection using short reads.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.